Format

Send to

Choose Destination
Oncogene. 2008 Jun 5;27(25):3635-40. doi: 10.1038/sj.onc.1211012. Epub 2008 Jan 21.

Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer.

Author information

1
Department of Pathology, Stanford University, Stanford, CA 94305-5176, USA.

Abstract

Lung cancer is a leading cause of cancer death, where the amplification of oncogenes contributes to tumorigenesis. Genomic profiling of 128 lung cancer cell lines and tumors revealed frequent focal DNA amplification at cytoband 14q13.3, a locus not amplified in other tumor types. The smallest region of recurrent amplification spanned the homeobox transcription factor TITF1 (thyroid transcription factor 1; also called NKX2-1), previously linked to normal lung development and function. When amplified, TITF1 exhibited increased expression at both the RNA and protein levels. Small interfering RNA (siRNA)-mediated knockdown of TITF1 in lung cancer cell lines with amplification led to reduced cell proliferation, manifested by both decreased cell-cycle progression and increased apoptosis. Our findings indicate that TITF1 amplification and overexpression contribute to lung cancer cell proliferation rates and survival and implicate TITF1 as a lineage-specific oncogene in lung cancer.

PMID:
18212743
PMCID:
PMC2903002
DOI:
10.1038/sj.onc.1211012
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center